Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Asian Journal of Andrology ; (6): 305-310, 2022.
Article in English | WPRIM | ID: wpr-928535

ABSTRACT

To reduce treatment-related side effects in low-risk prostate cancer (PCa), both focal therapy and deferred treatments, including active surveillance (AS) and watchful waiting (WW), are worth considering over radical prostatectomy (RP). Therefore, this study aimed to compare long-term survival outcomes between focal therapy and AS/WW. Data were obtained and analyzed from the Surveillance, Epidemiology, and End Results (SEER) database. Patients with low-risk PCa who received focal therapy or AS/WW from 2010 to 2016 were included. Focal therapy included cryotherapy and laser ablation. Multivariate Cox proportional hazards models were used to compare overall mortality (OM) and cancer-specific mortality (CSM) between AS/WW and focal therapy, and propensity score matching (PSM) was performed to reduce the influence of bias and unmeasured confounders. A total of 19 292 patients with low-risk PCa were included in this study. In multivariate Cox proportional hazards model analysis, the risk of OM was higher in patients receiving focal therapy than those receiving AS/WW (hazard ratio [HR] = 1.35, 95% confidence interval [CI]: 1.02-1.79, P = 0.037), whereas no significant difference was found in CSM (HR = 0.98, 95% CI: 0.23-4.11, P = 0.977). After PSM, the OM and CSM of focal therapy and AS/WW showed no significant differences (HR = 1.26, 95% CI: 0.92-1.74, P = 0.149; and HR = 1.26, 95% CI: 0.24-6.51, P = 0.782, respectively). For patients with low-risk PCa, focal therapy was no match for AS/WW in decreasing OM, suggesting that AS/WW could bring more overall survival benefits.


Subject(s)
Humans , Male , Propensity Score , Proportional Hazards Models , Prostatectomy/methods , Prostatic Neoplasms/surgery , Watchful Waiting
2.
Univ. med ; 58(3)2017. tab
Article in Spanish | LILACS, COLNAL | ID: biblio-996149

ABSTRACT

Objectives: lo describe the histológica] findings in patients with prostate cáncer (PCa) dmically dassifíed as very low risk who underwent treatment with radical prostatectomy (RP). Material and methods: A retrospective observational study was conducted. Clinical records of patients who underwent RP between 2007'2015 who met Epstein criteria for very low risk disease were reviewed. Histológica! diagnosis was described and analyzed to determine ¿f such criteria predicted very low risk. Results: A total of 609 records were reviewed; 83 (13.6%) met Epstein's criteria. Mean age was 59 (SD±7) years and median PSA at diagnosis was 5.4 ng'dl (IQR 4.3 ­ 6.8). Pathology showed a median tumor volume of 4% (IQR 1 ­ 10%). Gleason score was 3+3 in 55 (66.3%) cases, but 28 (33.7%) were redassified to a greater score. Two (2.4%) patients were redassified as pT3a, 80 (96.4%) as pT2 and 1 (1.2%) was found to be pTO. In those subjected to pelvic lymphadenectomy (42.2%) no positive lymph nodes were found. Conclusions: Up to one-third of the patients dinically classmed with very low risk PCa had a greater Gleason score. Only 3% had locally advanced tumors, which is comparable to previous studies. Epstein's criteria seem to be adequate in predicting organ-conñned disease.


Objetivo: Describir los hallazgos de la patología definitiva de los pacientes inicialmente clasificados con tumores de muy bajo riesgo que fueron llevados a prostatectomía radical (PR). Materiales y métodos: Estudio observacional retrospectivo. Se revisaron las historias clínicas de pacientes llevados a PR entre enero de 2007 y diciembre de 2015. Se describieron y analizaron los hallazgos histopatológicos posquirúrgicos, con el objetivo de determinar si cumplir con dichos criterios eran predictores de enfermedad órgano'confinada y de bajo riesgo. Resultados: Se revisaron 609 historias clínicas de pacientes llevados a PR, de las cuales 53 (13,6%) casos cumplían con criterios de muy bajo riesgo. La media de edad de estos pacientes fue de 59 (DE ± 7) años y la mediana de PSA al diagnóstico fue de 5,4 (RIQ 4,3'6,8) ng'dl. En la patología definitiva, la mediana del volumen tumoral fue del 4% (RIQ: 1'10%). El puntaje de Gleason fue de 3 + 3 en 55 (66,3%) pacientes, mientras que 28 (33,7 %) fueron reclasificados a uno mayor Solo 2 (2,4%) pacientes se reclasificaron como pT3a, 80 (96,4 %) pacientes fueron clasificados como pT2 y un (1,2 %) paciente fue reclasificado como pTO. No se evidenció compromiso ganglionar en ninguno de los pacientes llevados a linfadenectomía. Conclusión: Los hallazgos demuestran que hasta una tercera parte de los pacientes con tumores inicialmente clasificados como de muy bajo riesgo tienen puntajes de Gleason mayor en la patología definitiva; sin embargo, solo el 3 % tienen tumores localmente avanzados, lo cual es consistente con lo reportado en la literatura mundial. Los criterios de Epstein son adecuados para predecir la presencia de tumores órgano-confinados.


Subject(s)
Prostatectomy , Prostatic Neoplasms/diagnosis , Neoplasms/classification
SELECTION OF CITATIONS
SEARCH DETAIL